The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1973, 111: 921-929.
Copyright © 1973 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Philpott, G. W.
Right arrow Articles by Parker, C. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Philpott, G. W.
Right arrow Articles by Parker, C. W.

Selective Cytotoxicity of Hapten-Substituted Cells with an Antibody-Enzyme Conjugate1

Gordon W. Philpott2, William T. Shearer3, Richard J. Bower and Charles W. Parker

From the Departments of Surgery and Medicine, Washington University Medical School, St. Louis, Missouri 63110

Abstract

Affinity iodination and cytotoxicity of hapten-substituted tumor cells were accomplished with an anti-hapten antibody conjugated to glucose oxidase (which generates H2O2) and lactoperoxidase (which iodinates cells in the presence of H2O2 and I-). Polynitrophenylated HeLa and Hep-2 cells, obtained by brief incubation with 2,4,6, trinitrophenyl (TNP)-sulfonic acid, were selectively iodinated and killed when treated briefly with an anti-TNP antibody-glucose oxidase conjugate (Ab-GO) and cultured in media containing lactoperoxidase (LP) and iodide. Cell killing was determined by three methods: 1) a microcytotoxicity assay, 2) the loss of cells prelabeled with 125IUdR and 3) the degree of incorporation of 125IUdR after treatment (postlabeling). Results with the three independent methods showed cytotoxicity, ranging from 19% to 98% in TNP-cells incubated with Ab-GO (0.6 to 57 µg/ml), LP (50 µg/ml), and iodide (20 µM). {varepsilon}-DNP-lysine (100 µM) significantly reduced the amount of killing and minimal cytotoxicity (0 to 35%) was seen with unsubstituted cells or if Ab-GO, LP, or I- were omitted.

Footnotes

1 This work was supported by NCI Grants 5R01 CA12626 and AI00219.

2 Address Correspondence to: Gordon W. Philpott, M.D., Department of Surgery, Washington University Medical School, 4960 Audubon Avenue, St. Louis, Mo. 63110.

3 W. T. S. is United States Public Health Service Special Research Fellow from the National Institute of Allergy and Infectious Diseases, 1-F03-AI 53856-01.




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
M. Rooseboom, J. N. M. Commandeur, and N. P. E. Vermeulen
Enzyme-Catalyzed Activation of Anticancer Prodrugs
Pharmacol. Rev., March 1, 2004; 56(1): 53 - 102.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
W. T. Shearer, G. W. Philpott, and C. W. Parker
Stimulation of Cells by Antibody
Science, December 28, 1973; 182(4119): 1357 - 1359.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1973 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1973 by The American Association of Immunologists, Inc. All rights reserved.